Treatment journey in rheumatoid arthritis with biosimilars: from better access to good disease control through cost savings and prevention of nocebo effects

Early diagnosis and treatment of rheumatoid arthritis (RA) are of critical importance to halt the progression of the disease. Optimal use of advanced imaging techniques or biomarkers may facilitate early diagnosis of RA. Even though many disease-modifying anti-rheumatic drugs (DMARDs) are available...

Descripción completa

Detalles Bibliográficos
Autores principales: Smolen, Josef S, Caporali, Roberto, Doerner, Thomas, Fautrel, Bruno, Benedetti, Fabrizio, Pieper, Burkhard, Jang, Minjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Rheumatoid Arthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8186742/
https://www.ncbi.nlm.nih.gov/pubmed/34099538
http://dx.doi.org/10.1136/rmdopen-2021-001637

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8186742/
https://www.ncbi.nlm.nih.gov/pubmed/34099538
http://dx.doi.org/10.1136/rmdopen-2021-001637

Ejemplares similares